Unknown PHASE4 INTERVENTIONAL 4-arm NCT02954029

Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures

Sponsor: Seoul National University Bundang Hospital

Conditions Coronary Artery Disease Puncture

Interventions BloodSTOP ix pad Rotary compression device ezClot (hemostasis pad)

Updated 7 times since 2017 Last updated: Nov 2, 2016 Started: Apr 30, 2016 Primary completion: Dec 31, 2016 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Artery Disease and Puncture, this trial is ongoing. The trial is conducted by Seoul National University Bundang Hospital and has accumulated 7 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Dec 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Dec 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seoul National University Bundang Hospital

Data source: Seoul National University Bundang Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seongnam-si, South Korea